Oldies but Goodies: Thiazolidinedione as an Insulin Sensitizer with Cardioprotection

被引：6
作者：
Cho, Eun-Hee [1 ,2 ]
机构：
[1] Kangwon Natl Univ, Dept Internal Med, Sch Med, Chunchon, South Korea
[2] Kangwon Natl Univ, Dept Internal Med, Sch Med, 1 Gangwondaehak gil, Chunchon 24341, South Korea
来源：
DIABETES & METABOLISM JOURNAL | 2022年 / 46卷 / 06期
关键词：
CLINICAL-TRIAL; PIOGLITAZONE; METFORMIN; DRUG;
D O I：
10.4093/dmj.2022.0372
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：827 / 828
页数：2
相关论文
共 12 条
[1]   9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022 [J].
American Diabetes Association Professional Practice Committee .
DIABETES CARE, 2022, 45 :S125-S143
[2]   Diabetes Fact Sheet in Korea 2021 [J].
Bae, Jae Hyun ;
Han, Kyung-Do ;
Ko, Seung-Hyun ;
Yang, Ye Seul ;
Choi, Jong Han ;
Choi, Kyung Mook ;
Kwon, Hyuk-Sang ;
Won, Kyu Chang .
DIABETES & METABOLISM JOURNAL, 2022, 46 (03) :417-426
[3]   Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes [J].
DeFronzo, Ralph A. ;
Inzucchi, Silvio ;
Abdul-Ghani, Muhammad ;
Nissen, Steven E. .
DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (02) :133-143
[4]   Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].
Dormandy, JA ;
Charbonnel, B ;
Eckland, DJA ;
Erdmann, E ;
Massi-Benedetti, M ;
Kmoules, IK ;
Skene, AM ;
Tan, MH ;
Lefébvre, PJ ;
Murray, GD ;
Standl, E ;
Wilcox, RG ;
Wlhelmsen, L ;
Betteridge, J ;
Birkeland, K ;
Golay, A ;
Heine, RJ ;
Korányi, L ;
Laakso, M ;
Mokán, M ;
Norkus, A ;
Pirags, V ;
Podar, T ;
Scheen, A ;
Scherbaum, W ;
Schernthaner, G ;
Schmitz, O ;
Skrha, J ;
Smith, U ;
Taton, J .
LANCET, 2005, 366 (9493) :1279-1289
[5]   Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension [J].
Jin, S-M ;
Park, C-Y ;
Cho, Y. M. ;
Ku, B. J. ;
Ahn, C. W. ;
Cha, B-S ;
Min, K. W. ;
Sung, Y. A. ;
Baik, S. H. ;
Lee, K. W. ;
Yoon, K-H ;
Lee, M-K ;
Park, S. W. .
DIABETES OBESITY & METABOLISM, 2015, 17 (06) :599-602
[6]   Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy [J].
Kahn, Steven E. ;
Haffner, Steven M. ;
Heise, Mark A. ;
Herman, William H. ;
Holman, Rury R. ;
Jones, Nigel P. ;
Kravitz, Barbara G. ;
Lachin, John M. ;
O'Neill, M. Colleen ;
Zinman, Bernard ;
Viberti, Giancarlo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2427-2443
[7]   Pioglitazone after Ischemic Stroke or Transient Ischemic Attack [J].
Kernan, W. N. ;
Viscoli, C. M. ;
Furie, K. L. ;
Young, L. H. ;
Inzucchi, S. E. ;
Gorman, M. ;
Guarino, P. D. ;
Lovejoy, A. M. ;
Peduzzi, P. N. ;
Conwit, R. ;
Brass, L. M. ;
Schwartz, G. G. ;
Adams, H. P., Jr. ;
Berger, L. ;
Carolei, A. ;
Clark, W. ;
Coull, B. ;
Ford, G. A. ;
Kleindorfer, D. ;
O'Leary, J. R. ;
Parsons, M. W. ;
Ringleb, P. ;
Sen, S. ;
Spence, J. D. ;
Tanne, D. ;
Wang, D. ;
Winder, T. R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (14) :1321-1331
[8]   A Real-World Study of Long-Term Safety and Efficacy of Lobeglitazone in Korean Patients with Type 2 Diabetes Mellitus [J].
Kim, Bo-Yeon ;
Kwon, Hyuk-Sang ;
Kim, Suk Kyeong ;
Noh, Jung-Hyun ;
Park, Cheol-Young ;
Park, Hyeong-Kyu ;
Song, Kee-Ho ;
Won, Jong Chul ;
Yu, Jae Myung ;
Lee, Mi Young ;
Lee, Jae Hyuk ;
Lim, Soo ;
Chun, Sung Wan ;
Jeong, In-Kyung ;
Chung, Choon Hee ;
Han, Seung Jin ;
Kim, Hee-Seok ;
Min, Ju-Young ;
Kim, Sungrae .
DIABETES & METABOLISM JOURNAL, 2022, 46 (06) :855-865
[9]   Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks [J].
Kim, Sin Gon ;
Kim, Kyoung Jin ;
Yoon, Kun Ho ;
Chun, Sung Wan ;
Park, Kyong Soo ;
Choi, Kyung Mook ;
Lim, Soo ;
Mok, Ji-Oh ;
Lee, Hyoung Woo ;
Seo, Ji A. ;
Cha, Bong-Soo ;
Kim, Mi Kyung ;
Shon, Ho Sang ;
Choi, Dong Seop ;
Kim, Doo Man .
DIABETES OBESITY & METABOLISM, 2020, 22 (10) :1869-1873
[10]   Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial [J].
Kim, Sin Gon ;
Kim, Doo Man ;
Woo, Jeong-Taek ;
Jang, Hak Chul ;
Chung, Choon Hee ;
Ko, Kyung Soo ;
Park, Jeong Hyun ;
Park, Yong Soo ;
Kim, Sang Jin ;
Choi, Dong Seop .
PLOS ONE, 2014, 9 (04)
12